ECOR logo

ECOR
ElectroCore Inc

9,146
Mkt Cap
$54.97M
Volume
89,528.00
52W High
$8.64
52W Low
$4.16
PE Ratio
-4.17
ECOR Fundamentals
Price
$7.04
Prev Close
$6.80
Open
$6.84
50D MA
$6.54
Beta
1.02
Avg. Volume
61,978.45
EPS (Annual)
-$1.65
P/B
-32.97
Rev/Employee
$385,927.71
$35.84
Loading...
Loading...
News
all
press releases
Relay Therapeutics (RLAY) Surges 16.4%: Is This an Indication of Further Gains?
Relay Therapeutics (RLAY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Zacks·15h ago
News Placeholder
More News
News Placeholder
Analysts Offer Predictions for electroCore FY2030 Earnings
electroCore, Inc. (NASDAQ:ECOR - Free Report) - Equities researchers at HC Wainwright lifted their FY2030 earnings per share estimates for shares of electroCore in a research note issued to investors on Friday, March 20th. HC Wainwright analyst S. Ramakanth now anticipates that the company will post...
MarketBeat·15d ago
News Placeholder
electroCore (NASDAQ:ECOR) Releases Quarterly Earnings Results, Beats Estimates By $0.01 EPS
electroCore (NASDAQ:ECOR - Get Free Report) issued its earnings results on Thursday. The company reported ($0.34) earnings per share for the quarter, topping the consensus estimate of ($0.35) by $0.01. The firm had revenue of $9.24 million for the quarter, compared to analyst estimates of $9.09...
MarketBeat·18d ago
News Placeholder
electroCore (ECOR) Q4 2025 Earnings Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets·18d ago
News Placeholder
electroCore Q4 Earnings Call Highlights
electroCore (NASDAQ:ECOR) executives highlighted record fourth-quarter revenue growth, expanding adoption within the U.S. Department of Veterans Affairs (VA) system, and accelerating sales of its Truvaga wellness product during the company's fourth-quarter and full-year 2025 earnings call. Managemen...
MarketBeat·18d ago
News Placeholder
electroCore, Inc. (ECOR) Reports Q4 Loss, Lags Revenue Estimates
electroCore (ECOR) delivered earnings and revenue surprises of +1.45% and -0.18%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·18d ago
News Placeholder
MARKER THERAPEUTICS, INC. (MRKR) Reports Q4 Loss, Tops Revenue Estimates
MARKER THERAPEUTICS (MRKR) delivered earnings and revenue surprises of +80.49% and +83.83%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·19d ago
News Placeholder
Analysts Estimate Nektar Therapeutics (NKTR) to Report a Decline in Earnings: What to Look Out for
Nektar (NKTR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·1mo ago
News Placeholder
OmniAb, Inc. (OABI) Reports Q4 Loss, Misses Revenue Estimates
OmniAb, Inc. (OABI) delivered earnings and revenue surprises of -33.33% and -5.14%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
electroCore, Inc. (ECOR) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
electroCore (ECOR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·1mo ago
<
1
2
...
>

Latest ECOR News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.